Status:

COMPLETED

Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime

Lead Sponsor:

Sir Salimullah Medical College Mitford Hospital

Conditions:

Organophosphorus Poisoning

Eligibility:

All Genders

12+ years

Phase:

PHASE2

Brief Summary

This open level randomized controlled trial will be conducted in the department of medicine at Sir Salimullah Medical College and Mitford Hospital. Clinical severity will be assessed by the POP (Perad...

Detailed Description

OPC poisoning is one of the most medical emergencies manage in hospital in our country. For the treatment of this acute cases, along with the supportive measures, intravenous anticholinergic atropine ...

Eligibility Criteria

Inclusion

  • Patient having history of organophosphorus poisoning within 24 hours with features of moderate severity. (POP scale score 4-7)
  • Age above 12 years

Exclusion

  • Mixed poisons along with organophosphorus compound,
  • Patients with known case chronic diseases such as chronic lung disease, chronic kidney disease, Heart failure, malignancy, chronic liver disease

Key Trial Info

Start Date :

June 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2023

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT06111352

Start Date

June 1 2022

End Date

September 30 2023

Last Update

October 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sir Salimullah Medical College Mitford Hospital

Dhaka, Bangladesh, 1100

Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime | DecenTrialz